Collectively, these studies indicate that recurrent alterations in the levels of positive and negative BCR signaling regulators intrinsically affect the nature of BCR signaling and may contribute to the pathogenesis of CLL. The gene discussed is BCR; the disease is B-cell chronic lymphocytic leukemia.